All locations are open. Call your doctor today to schedule an in-person appointment or a doctor video visit.
Learn about our COVID-SAFE Care • Latest Visitor Policy and Service Updates • Donate and Lend Support


Todos los centros abiertos. Llame al médico hoy para una cita en persona o para una video visita médica.
Sepa qué es la Salud A SALVO DE COVID • Novedades de servicios y normas de visitas • Done y dé apoyo

Learn more
Search Clinical Trials
Home >  Clinical Trials & Research >  Search Clinical Trials
Print

Clinical Trials & Research

Search Clinical Trials

Clinical Trials

New Search
Title   A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With = 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN+) After Neoadjuvant Chemotherapy
Disease/Condition   Breast Cancer,Women`s Health,Oncology (Medical/Hematologic),Carcinoma,Neoplasms
Description  

Click here for more information

Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Jesus Anampa Mesias, MD
Contact Name   Amanda Erakky
Contact Email   aerakky@montefiore.org
Protocol Number   2018-9832
Inclusion/Notes   This Information was obtained from ClinicalTrials.gov
Status   Active/Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No
Sub-Specialty   Medical and Hematologic Oncology - Breast
Adult, Pediatric, Both   Adult